RW
Robert Weisskoff
OtherQuietPartner at F-Prime Capital Partners
3
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Robert Weisskoff.
Investment Thesis & Strategy
Robert Weisskoff, as a partner at F-Prime Capital Partners, invests in various stages of biotech, health & hospital services, health IT, medical devices, and pharmaceutical companies. They seek to invest in innovative companies within the healthcare sector.
Investment Activity
Deals per year over the last 12 years
1
20100
20110
20120
20130
20140
20150
20161
20170
20180
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 3 companies
A
Adela
Biotech · Series A, 2021
T
Tempest Therapeutics
Biotech · Series B, 2017
P
PlasmaGen Biosciences
Biotech · Series A, 2010
Frequently Asked Questions
Robert Weisskoff focuses on Series A stage investments.
Related Investors
Shawn Broderick
Massachusetts, United States · 120 deals
Rich Levandov
Massachusetts, United States · 61 deals
Roger Kitterman
Massachusetts, United States · 27 deals
Mike Troiano
Massachusetts, United States · 19 deals
David Orfao
Massachusetts, United States · 9 deals
Mark Roberge
Massachusetts, United States · 3 deals